ARHGEF1 and breast carcinoma: In this light, cortactin may be considered an adaptor protein for ROR1, functioning to enhance cell migration and/or metastasis by recruiting and activating ARHGEF1 to ROR1 to provide localized activation of RhoA.44 Consistent with this model is the observation that breast-cancer cells with reduced levels of cortactin following treatment with cortactin-specific siRNA had reduced chemotaxis in response to Wnt5a, implicating that cortactin plays a critical role in breast-cancer-cell migration/metastasis.